• About us
  • Privacy Policy
  • Contact us
Neo Science Hub
ADVERTISEMENT
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
Neo Science Hub
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Revitalizing Indian Pharma: The Katoch Committee’s Blueprint

Rashmi NSH by Rashmi NSH
2 years ago
in Science News
0
katoch

The Indian pharmaceutical industry, recognized globally for its substantial contributions, has faced numerous challenges including high dependency on imported raw materials and regulatory complexities. To address these issues and bolster domestic manufacturing, the Katoch Committee, led by Dr. V.M. Katoch, was formed. The committee’s recommendations, laid out in 2015, aim to revitalize the sector and reduce dependence on imports, particularly from China.

Main Recommendations of the Katoch Committee

1. Establishment of Mega Pharma Parks: The committee recommended the creation of Large Manufacturing Zones (LMZs) or Mega Parks for APIs with integrated facilities like Effluent Treatment Plants (ETPs) and testing facilities. These parks would be maintained by a Special Purpose Vehicle (SPV) and provided at concessional rates to stimulate domestic production.

2. Single Window Clearance: To reduce bureaucratic red tape and encourage ease of doing business, the committee suggested implementing a single window clearance system for drug licensing in India.

3. Formation of National Bulk Drugs Development Authority: This body would oversee and drive the growth of the bulk drugs market, ensuring that India can meet its requirements internally.

4. Empowered Panel of Secretaries: The committee proposed setting up a panel headed by the Secretary of Pharmaceuticals to streamline decisions involving multiple ministries, ensuring faster and more efficient policy implementation.

5. Fiscal and Financial Incentives: Recommendations include tax benefits, soft loans with interest subvention, and financial support for setting up infrastructure in Mega Pharma Parks. These measures are aimed at making the Indian pharmaceutical sector more self-reliant and globally competitive.

6. Incentives for R&D: The committee highlighted the need for stronger industry-academia interaction and suggested measures like tax rebates for upgrading R&D facilities to foster innovation.

7. Strengthening Regulatory Compliance: There was a strong emphasis on improving the quality control standards and regulatory compliance, to maintain trust in Indian pharmaceutical products globally.

Implementation & Impact

The implementation of these recommendations has been gradual and mixed. Some initiatives like the proposal for mega pharma parks have seen progress, while others like the single window clearance system require more robust efforts to be fully realized. The overarching goal remains to make India a global hub for pharmaceuticals, mirroring its position in the generic drugs market.

The Katoch Committee’s recommendations, if implemented effectively, have the potential to significantly transform India’s pharmaceutical landscape. By reducing import dependency, enhancing product quality, and fostering innovation, India can solidify its standing as a global pharmaceutical powerhouse. This strategic shift is not just about economic gains but also about ensuring national health security in a rapidly changing global health environment.

–NSH Digi Desk

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Telegram (Opens in new window) Telegram
  • Email a link to a friend (Opens in new window) Email
Tags: pharmaPrice Erosionsciencenews
Rashmi NSH

Rashmi NSH

Other Posts

Bar chart of decreasing bars beside a line-art antibiotic icon

When the Last Antibiotic Fails: ICMR Finds 91 Per Cent Carbapenem Resistance in a Common Hospital Pathogen

November 21, 2026
0
Map of India's east coast with a stylised cyclone and its forecast track

Akvan Turns North and Drops a Category: IMD Now Expects a Severe Cyclone Between Narsapur and Puri, While Andhra’s Own Forecasters Expect Less

November 21, 2026
0

Antalya’s Last Forty-Eight Hours: Two Contradictory Paragraphs on Fossil Fuels, and India’s Line on the Carbon Budget

Disarm, Don’t Kill: CCMB Scientists Find Two Compounds That Stop a Deadly Fungus Turning Invasive

Eighty Per Cent of the Cost: Andhra Pradesh Raises the Stakes in India’s Chip-Subsidy Contest

Before the First Breath: UNEP and WHO Say Hormone-Disrupting Chemicals Reach Us in the Womb

The Morning Eye Closes: NASA Will Switch Off Terra After 27 Years of Watching the Planet

A Status Lost: Measles Is Endemic Again in the United States, Mexico and Bolivia

Next Post
Trump Card

Trump Card: A Rally in Indian IT Stocks

Subscribe to Us

Latest Articles

Cross-section of a human eye with the optic nerve head highlighted

FDA Orders Eye-Risk Warnings on All GLP-1 Drugs, From Ozempic to Mounjaro

November 12, 2026
11

Delhi’s Diwali, Measured: Firecrackers Drove 71% of Fine Particles, Lead Hit 20 Times the Limit, and the Worst Readings Went Missing

Global Carbon Budget 2026: The World’s Fossil Emissions Dip, India’s Rise 4.4%, and the 1.5 °C Budget Is Nearly Spent

A New Kind of Blood Thinner: FDA Approves Asundexian to Prevent Repeat Strokes

Andhra Pradesh Opens the Door to Small Nuclear Reactors, Robots and Giga-Scale AI Data Centres — With the Details Still to Come

“Off the Charts”: WMO Tells COP31 That 2026 Is Among the Hottest Years on Record as a Record El Niño Builds

  • Advertise
  • Terms and Conditions
  • Privacy Policy
  • Refund Policy
  • Contact
For Feedback : Email Us

Copyrights © 2025 Neo Science Hub

No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Copyrights © 2025 Neo Science Hub

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist